Management of patients with advanced prostate cancer in the Asia Pacific region: 'real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017

BJU International
Edmund ChiongI D Davis

Abstract

The Asia Pacific Advanced Prostate Cancer Consensus Conference (APAC APCCC 2018) brought together 20 experts from 15 APAC countries to discuss the real-world application of consensus statements from the second APCCC held in St Gallen in 2017 (APCCC 2017). Differences in genetics, environment, lifestyle, diet and culture are all likely to influence the management of advanced prostate cancer in the APAC region when compared with the rest of the world. When considering the strong APCCC 2017 recommendation for the use of upfront docetaxel in metastatic castration-naïve prostate cancer, the panel noted possible increased toxicity in Asian men receiving docetaxel, which would affect this recommendation in the APAC region. Although androgen receptor-targeting agents appear to be well tolerated in Asian men with metastatic castration-resistant prostate cancer, access to these drugs is very limited for financial reasons across the region. The meeting highlighted that cost and access to contemporary treatments and technologies are key factors influencing therapeutic decision-making in the APAC region. Whilst lower cost/older treatments and technologies may be an option, issues of culture and patient or physician preference mean, these ma...Continue Reading

References

Dec 31, 2003·International Journal of Radiation Oncology, Biology, Physics·Deepinder SinghPaul Okunieff
Oct 8, 2004·The New England Journal of Medicine·Ian F TannockUNKNOWN TAX 327 Investigators
Sep 8, 2010·The New England Journal of Medicine·Philip W KantoffUNKNOWN IMPACT Study Investigators
Aug 17, 2012·The New England Journal of Medicine·Howard I ScherUNKNOWN AFFIRM Investigators
Jul 19, 2013·The New England Journal of Medicine·C ParkerUNKNOWN ALSYMPCA Investigators
Nov 2, 2013·The Lancet Oncology·Scott WilliamsUNKNOWN Asian Oncology Summit 2013
Jun 3, 2014·The New England Journal of Medicine·Tomasz M BeerUNKNOWN PREVAIL Investigators
Jul 15, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas J SmithJames O Armitage
Jul 25, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C ParkerUNKNOWN ESMO Guidelines Committee
Aug 6, 2015·The New England Journal of Medicine·Christopher J SweeneyRobert S DiPaola
Nov 3, 2016·Nature Reviews. Urology·Jeffrey J TosoianEdward M Schaeffer
Oct 12, 2016·AJR. American Journal of Roentgenology·Tristan Barrett, Masoom A Haider
Feb 22, 2017·CA: a Cancer Journal for Clinicians·Mark K BuyyounouskiDaniel W Lin
Jun 6, 2017·The New England Journal of Medicine·Karim FizaziUNKNOWN LATITUDE Investigators
Jun 6, 2017·The New England Journal of Medicine·Nicholas D JamesUNKNOWN STAMPEDE Investigators
Feb 1, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christos E KyriakopoulosChristopher J Sweeney
Mar 29, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Russell Z SzmulewitzMark J Ratain
May 23, 2018·Journal of the National Comprehensive Cancer Network : JNCCN·Robert A Swarm, Maria Dans
Sep 11, 2018·Journal of Oncology Practice·Justin E BekelmanStephen J Freedland

❮ Previous
Next ❯

Citations

Aug 23, 2019·Japanese Journal of Clinical Oncology·Taiji Tsukamoto
Oct 24, 2019·Asia-Pacific Journal of Clinical Oncology·Darren Ming-Chun PoonEddie Shu-Yin Chan
Oct 30, 2019·BJU International·Isaac A ThangasamyDeclan G Murphy
Dec 20, 2018·BJU International·Aurelius Omlin, Silke Gillessen
Aug 28, 2020·Asia-Pacific Journal of Clinical Oncology·Angus Kwong-Chuen Leung
Jan 4, 2020·World Journal of Urology·E M KwanA A Azad
Nov 13, 2020·Frontiers in Oncology·Samantha S SigurdsonFabio Ynoe de Moraes
Mar 12, 2021·Nature Reviews. Urology·Yao ZhuDingwei Ye
Mar 23, 2021·Therapeutic Advances in Medical Oncology·Fabio Augusto Barros SchutzAmit Garg
Sep 23, 2021·JCO Oncology Practice·Angelyn Anton, Ben Tran

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.